143 related articles for article (PubMed ID: 10458626)
1. Hydroxyurea as part of a salvage regimen for heavily pretreated patients with advanced HIV infection.
Grunke M; Dechant C; Löw P; Rascu A; Kalden JR; Harrer T
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):424-6. PubMed ID: 10458626
[No Abstract] [Full Text] [Related]
2. Is Hydroxyurea for real?
Mascolini M
J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):6-16, 18. PubMed ID: 11365731
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, safety and anti-human immunodeficiency virus (HIV) activity of hydroxyurea in combination with didanosine.
Luzzati R; Di Perri G; Fendt D; Ramarli D; Broccali G; Concia E
J Antimicrob Chemother; 1998 Oct; 42(4):565-6. PubMed ID: 9818769
[No Abstract] [Full Text] [Related]
4. Hydroxyurea-induced neurotoxicity in HIV disease.
Barry M; Clarke S; Mulcahy F; Back D
AIDS; 1999 Aug; 13(12):1592-4. PubMed ID: 10465092
[No Abstract] [Full Text] [Related]
5. Hydroxyurea-induced nail pigmentation in HIV patients.
Joyner S; Lee D; Hay P; Lau R
HIV Med; 1999 Oct; 1(1):40-2. PubMed ID: 11737328
[TBL] [Abstract][Full Text] [Related]
6. [Hydroxyurea and HIV infection].
Nkoghe D; Kola L; Léonard P; Demonty J; Moutschen M
Rev Med Liege; 2000 Jul; 55(7):721-4. PubMed ID: 11014107
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea and HIV: 5 years later--from antiviral to immune-modulating effects.
Lori F
AIDS; 1999 Aug; 13(12):1433-42. PubMed ID: 10465065
[No Abstract] [Full Text] [Related]
8. Hydroxyurea in the treatment of HIV-1.
Gibbs MA; Sorensen SJ
Ann Pharmacother; 2000 Jan; 34(1):89-93. PubMed ID: 10669190
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART).
Stebbing J; Nelson M; Orkin C; Mandalia S; Bower M; Pozniak A; Gazzard B
J Antimicrob Chemother; 2004 Mar; 53(3):501-5. PubMed ID: 14762056
[TBL] [Abstract][Full Text] [Related]
10. Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide.
Vila J; Nugier F; Barguès G; Vallet T; Peyramond D; Hamedi-Sangsari F; Seigneurin JM
Lancet; 1997 Aug; 350(9078):635-6. PubMed ID: 9288048
[No Abstract] [Full Text] [Related]
11. Hydroxyurea - new observations.
Proj Inf Perspect; 1998 Apr; (24):15-7. PubMed ID: 11365714
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine+ddI+Hydroxyurea antiretroviral trial, AIDS Research Alliance, Los Angeles.
AIDS Treat News; 1999 Dec; (No 332):8. PubMed ID: 11367131
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of hydroxyurea.
Gwilt PR; Tracewell WG
Clin Pharmacokinet; 1998 May; 34(5):347-58. PubMed ID: 9592619
[TBL] [Abstract][Full Text] [Related]
14. Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.
Frank I; Bosch RJ; Fiscus S; Valentine F; Flexner C; Segal Y; Ruan P; Gulick R; Wood K; Estep S; Fox L; Nevin T; Stevens M; Eron JJ;
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):916-26. PubMed ID: 15597521
[TBL] [Abstract][Full Text] [Related]
15. The HYDILE trial: efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinations.
Lafeuillade A; Hittinger G; Chadapaud S; Maillefet S; Rieu A; Poggi C
HIV Clin Trials; 2002; 3(4):263-71. PubMed ID: 12187499
[TBL] [Abstract][Full Text] [Related]
16. Drug Points: pancreatitis associated with hydroxyurea in combination with didanosine.
Longhurst HJ; Pinching AJ
BMJ; 2001 Jan; 322(7278):81. PubMed ID: 11154621
[No Abstract] [Full Text] [Related]
17. Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters.
Lori F; Rosenberg E; Lieberman J; Foli A; Maserati R; Seminari E; Alberici F; Walker B; Lisziewicz J
AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1333-8. PubMed ID: 10515148
[TBL] [Abstract][Full Text] [Related]
18. What they say about complementary drugs.
Posit Aware; 1999; 10(1):45. PubMed ID: 11366524
[TBL] [Abstract][Full Text] [Related]
19. Immune restoration by combination of a cytostatic drug (hydroxyurea) and anti-HIV drugs (didanosine and indinavir).
Lori F; Jessen H; Lieberman J; Clerici M; Tinelli C; Lisziewicz J
AIDS Res Hum Retroviruses; 1999 May; 15(7):619-24. PubMed ID: 10331440
[TBL] [Abstract][Full Text] [Related]
20. Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea.
López M; Benito JM; Lozano S; Barreiro P; Martínez P; González-Lahoz J; Soriano V
AIDS; 2004 Jun; 18(9):1251-61. PubMed ID: 15362657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
